A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer
S J Schnitt, Jay R. Harris(Harvard University), Timothy J. Eberlein, Patti Cohen(Harvard University), Rebecca Gelman(Dana-Farber Cancer Institute), Susan M. Love(University of California, Los Angeles), Lindsey Schneider(Harvard University), Barbara Silver, Asa J. Nixon(Dana-Farber Brigham Cancer Center), Kathleen Mayzel(Brigham and Women's Faulkner Hospital), Abram Recht(Harvard University), Robert T. Osteen(John Brown University), James A. Hayman(University of Michigan), James L. Connolly(Beth Israel Deaconess Medical Center), Susan K. Pierce(National Institute of Allergy and Infectious Diseases)
Cited by 152
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|988
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
|Journal of Clinical Oncology|2010|983